CapsoVision (CV), a commercial-stage medical technology company that develops advanced imaging and artificial intelligence technologies that are deployed in its capsule endoscopy solutions, priced 5.5M shares at $5.00. The deal size was increased to 5.5M shares from 5.25M and priced at the low end of the $5.00-$5.50 range. Benchmark and Roth Capital are acting as joint book running managers for the offering.
Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.